PHARMACISTS' REPORT
 
New Drug Review: Tafamidis Meglumine for Cardiomyopathy
Approved in May 2019, granted to FoldRx, a subsidiary of Pfizer.
More
ADVERTISEMENT
 
Contemplating the Future of List Prices
image description here What experts think of the future of drug costs.

More
 
Dapagliflozin Approved to Reduce Hospitalization in Diabetes Patients
image description here Reduces risk for heart failure and cardiovascular disease hospitalizations.

More
 
Read More
 
5 Types of Diabetes Patients Who Need More Management
Transgender Patient Pharmacy Care
When Shingles Gets in Your Eyes
Surviving a 12-Hour Pharmacy Shift